BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Mirati Therapeutics Release: Initial Data From Ongoing Expansion Study Of MGCD265 Show Preliminary Evidence Of Clinical Efficacy In Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients With MET Gene Alterations

  June 1, 2015

   · 

  15 min read
• Pharm Country

  NYU Langone Medical Center Release: Contact Lens Wearers Take Note: Your Eyes May Get More Infections Because Their “Microbiomes” Have Changed

  June 1, 2015

   · 

  4 min read
• Drug Development

  PharmaEngine, Inc. Announces Filing New Drug Application (NDA) Of MM-398 (PEP02) To Taiwan FDA As A Treatment For Post-Gemcitabine Metastatic Pancreatic Cancer

  June 1, 2015

   · 

  3 min read
• Lone Star Bio

  Caris Life Sciences Presents New Tumor Profiling Research Providing Insights Into The Clinical Benefit Of Targeted Therapies For Colorectal Cancer Treatment-Resistant Subgroups

  June 1, 2015

   · 

  5 min read
• Business

  Rumor Has It: San Francisco’s Foresite Capital Closing Out $450 Million Life Science Fund

  June 1, 2015

   · 

  1 min read
• Drug Development

  ASCO15: Calithera Biosciences, Inc. Reports Phase I Data For CB-839 In Patients With Solid Tumors At The 2015 ASCO

  June 1, 2015

   · 

  6 min read
• Drug Development

  Astellas Pharma Inc. Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML)

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: Oncothyreon Inc. Announces Presentation Of Positive ONT-380 Data In HER2-Positive Breast Cancer At ASCO Annual Meeting And Updates Development Plan

  June 1, 2015

   · 

  6 min read
• Drug Development

  Array BioPharma, Inc. Release: Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential Differentiated Safety In BRAF-Mutant Melanoma

  June 1, 2015

   · 

  6 min read
• Drug Development

  ASCO15: Adaptimmune Announces Data From Clinical Studies Of NY-ESO-1 Specific T-Cells In Multiple Cancers At The 2015 Annual ASCO Meeting

  June 1, 2015

   · 

  7 min read